Hyperthermic Intra-Vesical Chemotherapy

NACompletedINTERVENTIONAL
Enrollment

259

Participants

Timeline

Start Date

May 8, 2014

Primary Completion Date

May 27, 2020

Study Completion Date

May 27, 2020

Conditions
Bladder Cancer
Interventions
DEVICE

Hyperthermia will be delivered in combination with each instillation using the Combat BRS system

The Combat BRS system is a temperature controlled fluid recirculation system for the delivery of hyperthermic intravesical chemotherapy. The chemotherapy fluid is circulated in a closed system and warmed by an external isolated dry system using a novel innovative laminated aluminium foil heat exchanger with a small priming volume.

Trial Locations (14)

Unknown

Royal United Hospitals Bath NHS Foundation Trust, Bath

Western General Hospital, Edinburgh, Edinburgh

The Clatterbridge Cancer Centre, Liverpool

Barnet Hospital, London

St George's University Hospitals NHS Foundation Trust, London

University College London Hospital, London., London

South Tees NHS Trust - James Cook University Hospital, Middlesbrough

Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich

Derriford Hospital, Plymouth

Portsmouth Hospitals NHS Trust - Queen Alexandra Hospital, Portsmouth

East Surrey Hospital, Redhill

New Cross Hospital, Wolverhampton

GU2 7XX

Royal Surrey County Hospital NHS Foudation Trust, Guildford

M239QZ

University Hospital of South Manchester, Manchester

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT06768346 - Hyperthermic Intra-Vesical Chemotherapy | Biotech Hunter | Biotech Hunter